News

$STLHF Announces Successfully Production of Battery Quality Lithium Carbonate Using OEM Technology

Standard Lithium (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF), an innovative technology and lithium project development company, today announced successful completion of its Arkansas-produced lithium chloride into 99.985% pure lithium carbonate using OEM technology. According to the update, Veolia Water Technologies completed the work at its facility in Plainfield, Illinois, which demonstrates that the lithium chloride intermediate product produced by Standard Lithium’s industrial scale LiSTR Direct Lithium Extraction (“DLE”) plant in Arkansas can be converted into better-than battery quality lithium carbonate using established OEM carbonation technology. “We’ve now demonstrated that we can convert to battery quality lithium carbonate using the company’s SiFT technology; that we can get to the same end-product using established technology developed and sold by global OEMs; and now we’re looking to add battery quality lithium hydroxide to the product offering,” said Dr. Andy Robinson, president and COO of Standard Lithium. “In the background, we continue to rapidly advance both project and corporate development work. We’re excited about reaching the various milestones ahead of us and, if we’re successful, taking this globally important project into commercialization.”

To view the full press release, visit http://ibn.fm/CB3HO

About Standard Lithium Ltd.

Standard Lithium is an innovative technology and lithium development company. The company’s flagship project is located in southern Arkansas, where it is engaged in the testing and proving of the commercial viability of lithium extraction from over 150,000 acres of permitted brine operations. The company has commissioned its first of a kind industrial scale Direct Lithium Extraction Demonstration Plant at LANXESS South Plant facility in southern Arkansas. The Demonstration Plant utilizes the company’s proprietary LiSTR technology to selectively extract lithium from LANXESS’ tailbrine. The Demonstration Plant is being used for proof-of-concept and commercial feasibility studies. The scalable, environmentally friendly process eliminates the use of evaporation ponds, reduces processing time from months to hours and greatly increases the effective recovery of lithium. The company is also pursuing the resource development of over 30,000 acres of separate brine leases located in southwestern Arkansas and approximately 45,000 acres of mineral leases located in the Mojave Desert in San Bernardino County, California.

Standard Lithium is listed on the TSX Venture Exchange under the trading symbol “SLL;” quoted on the OTC – Nasdaq Intl Designation under the symbol “STLHF” and on the Frankfurt Stock Exchange under the symbol “S5L.”  For more information, please visit the company’s website at www.StandardLithium.com.

NOTE TO INVESTORS: The latest news and updates relating to STLHF are available in the company’s newsroom at http://ibn.fm/STLHF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Monday, March 1st, 2021 News No Comments

$GNPX Announces Participation Schedule for March Investor Conferences

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced its plans to participate in two virtual investor conferences in the month of March. These include the Sachs 14th Annual European Life Sciences CEO Forum taking place March 10-12, as well as the 33rd Annual Roth Conference scheduled to be held from March 15-17, 2021. The company’s president and CEO, Rodney Varner, will lead Genprex’s presentations and will be available for one-on-one meetings with investors throughout the conferences. Interested parties should visit https://ibn.fm/MUouk and https://ibn.fm/J1qLh to register. The presentations will be available for replay on the company’s website for a period of time following the events.

To view the full press release, visit http://ibn.fm/K4xDf

About Genprex Inc.

Genprex is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Genprex’s technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. The company’s lead product candidate, “REQORSA(TM)” (quaratusugene ozeplasmid), is being evaluated as a treatment for non-small cell lung cancer (“NSCLC”). REQORSA has a multimodal mechanism of action that has been shown to interrupt cell signaling pathways that cause replication and proliferation of cancer cells; re-establish pathways for apoptosis, or programmed cell death, in cancer cells; and modulate the immune response against cancer cells. REQORSA has also been shown to block mechanisms that create drug resistance. In January 2020, the U.S. Food and Drug Administration granted Fast Track Designation for REQORSA for NSCLC in combination therapy with osimertinib (AstraZeneca’s Tagrisso(R)) for patients with EFGR mutations whose tumors progressed after treatment with osimertinib alone. For more information, visit the company’s web site at www.Genprex.com.

NOTE TO INVESTORS: The latest news and updates relating to GNPX are available in the company’s newsroom at http://ibn.fm/GNPX

About BioMedWire

BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Monday, March 1st, 2021 News No Comments

$FRSX Issues Shareholder Letter, Announces Successful Completion of Eye-Net Trial

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision systems, has released a shareholder update outlining the company’s stable business development and remarkable performance throughout 2020, as well as several key business milestones that have set the course for what Foresight believes will be a successful year. In addition, the company today announced that its wholly owned subsidiary, Eye-Net Mobile Ltd., successfully completed a controlled trial of its Eye-Net(TM) Protect cellular-based accident prevention solution for the intelligent transport system division of a multi-billion-dollar global Japanese vehicle manufacturer. Blue and White Robotics (“BWR”) supervised the trial that was designed to demonstrate Eye-Net’s advanced capabilities of protecting vehicles from oncoming collisions. “Eye-Net successfully completed another controlled trial and met all predefined objectives and key performance indicators, demonstrating Eye-Net Protect’s system capabilities. The system configuration used in the trial was almost identical to the production configuration, mimicking real-life situations with almost no safety margins,” said Dror Elbaz, COO and deputy CEO of Eye-Net Mobile. ”The test results confirm that the Eye-Net technology and product are ready for commercial deployment and may bring outstanding added value to all road users in general and to the automotive industry in particular.”

To view the full press releases, visit https://ibn.fm/FtBVW and https://ibn.fm/kh4Af

About Foresight Autonomous Holdings Ltd.

Foresight, founded in 2015, is a technology company engaged in the design, development and commercialization of sensors systems for the automotive industry. Through the company’s wholly owned subsidiaries, Foresight Automotive Ltd. and Eye-Net Mobile Ltd., Foresight develops both “in-line-of sight” vision systems and “beyond-line-of-sight” cellular-based applications. Foresight’s vision sensor is a four-camera system based on 3D video analysis, advanced algorithms for image processing, and sensor fusion. Eye-Net Mobile’s cellular-based application is a V2X (vehicle-to-everything) accident prevention solution based on real-time spatial analysis of clients’ movement.

The company’s systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is targeting the advanced driver assistance systems (“ADAS”), the semi-autonomous and autonomous vehicle markets and predicts that its systems will revolutionize automotive safety by providing an automotive-grade, cost-effective platform and advanced technology.

For more information about Foresight and its wholly owned subsidiary, Foresight Automotive, visit www.ForesightAuto.com

NOTE TO INVESTORS: The latest news and updates relating to FRSX are available in the company’s newsroom at http://ibn.fm/FRSX

About ChineseWire

ChineseWire (CW) is a specialized communications platform focused on promising China-based companies that are listed in North America. As one of 40+ brands within the InvestorBrandNetwork (“IBN”), CW provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) social media distribution to IBN’s millions of social media followers; and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, CW is uniquely positioned to best serve private and public Chinese companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, CW brings its clients unparalleled visibility, recognition and brand awareness. CW is where news, content and information converge.

For more information, please visit https://www.ChineseWire.com

Please see full terms of use and disclaimers on the ChineseWire website applicable to all content provided by CW, wherever published or re-published: https://www.ChineseWire.com/Disclaimer

ChineseWire
Los Angeles, California
www.ChineseWire.com
310.299.1717 Office
Editor@ChineseWire.com

ChineseWire is part of the InvestorBrandNetwork.

Monday, March 1st, 2021 News No Comments

$DRIO Hosting Conference Call to Release Q4, Full-Year Results

DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, will be hosting a conference call and webcast on Tuesday, March 9, 2021, ET. The purpose of the call is for the company to announce its fourth-quarter and fiscal year results. DRIO CEO Erez Raphael, president and general manager of North America Rick Anderson and CFO Zvi Ben-David will host the conference, which is scheduled to begin at 8:30 a.m. ET. Anyone interested in participating can dial in; callers are invited to join 10 minutes before the webcast begins by calling 877-451-6152 (domestic) or 201-389-0879 (international). The call will be available for replay about two hours after the call and will be available through April 9, 2021. The replay can be heard by dialing 844-512-2921 (domestic) or 412-317-6671 (international) and entering the replay passcode 13716928.

To view the webcast, visit http://ibn.fm/oczM6

To view the full press release, visit http://ibn.fm/4u0wV

About DarioHealth Corp.

DarioHealth Corp. is a leading global digital therapeutics company revolutionizing how people with chronic conditions manage their health. Dario’s next-generation, AI-powered, digital therapeutic solutions support more than just an individual’s disease. Dario provides adaptive, personalized experiences that drive behavior change through evidence-based interventions, intuitive, clinically proven digital tools, high-quality software and coaching to help individuals improve health and sustain meaningful outcomes. Dario offers one of the highest-rated diabetes and hypertension solutions on the market. The company’s cross-functional team operates at the intersection of life sciences, behavioral science, and software technology and is rapidly expanding into new chronic conditions and geographic markets, using a performance-based approach to improve its users’ health. Dario makes the right thing to do the easy thing to do. For more information about the company, please visit www.DarioHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Monday, March 1st, 2021 News No Comments

$AMST Announces It Will Focus on Whole Enterprise Solutions After Successful Implementation of Its SaaS Ed-Tech Platform for The Henry Ford Museum of American Innovation

ANN ARBOR, Mich. March 1, 2021 Amesite Inc . (Nasdaq: AMST), an ed-tech, SaaS company with the most advanced artificial intelligence driven online learning platform in the industry, providing both content creation and a best-in-class infrastructure for the multi-billion-dollar online learning markets in business and education, announced today the successful implementation of its whole enterprise solution for The Henry Ford Museum of American Innovation.

Amesite’s cloud-based platform and content creation services provide fully managed, customized, learning environments for business, universities, and K-12 schools. The platform has the capacity to upload an organization’s entire training and educational materials into a single point of access.

CEO and Founder Dr. Ann Marie Sastry , commented, “Being able to bring an entire organization into the Amesite platform is a crucial benchmark for the future of artificial intelligence-backed training and upskilling programs. We developed these solutions and scaled their capacity because we are increasingly hearing from companies that there is a critical need for wholesale improvement in the way they create and deliver content. Businesses and educational institutions are looking for cloud-based solutions that are engaging, easy-to-use, and deliver concrete measurable results, especially now that many companies are dealing with split remote and in-person workforces.”

Addressing a global online education market projected to grow to $319 billion by 2025, Amesite has been rapidly ramping up its capabilities to deliver whole-organization solutions for companies with large-scale educational, training and upskilling needs. It recently launched a complete online learning platform, inHub, for The Henry Ford Museum, an internationally recognized museum with more than 26 million primary and secondary source artifacts and lesson plans that detail more than 300 years of American innovation, ingenuity, and resourcefulness. A video detailing that launch can be found at: https://lp.amesite.com/thf-case-study .

“Initial results indicate that inHub is an unparalleled educational tool,” said Patricia Mooradian , President and CEO of The Henry Ford Museum.  “Amesite’s technology has made our system scalable, flexible, and easy-to-use so that we can fully achieve our goals of teaching and inspiring that next generation of innovators and inventors.”

Dr. Sastry further commented, “Providing an organization with the ability to migrate their entire training system into our AI-backed ecosphere is a gamechanger for those needing to provide learning solutions to thousands of employees or students. In just a short time, we have been able to scale our platforms from single courses to a point now that we can bring entire institutions on board quickly and seamlessly.”

ABOUT AMESITE
Amesite is an ed-tech, SaaS company with the most advanced artificial intelligence driven online learning platform in the industry, providing both content creation and a best-in-class infrastructure for the multi-billion-dollar online learning markets in business and education. For more information, visit www.Amesite.com .

Forward Looking Statements
This communication contains forward-looking statements (including within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended) concerning the Company, the Company’s planned online machine learning platform, the Company’s business plans, any future commercialization of the Company’s online learning solutions, potential customers, business objectives and other matters. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as “may,” “will,” “should,” “would,” “expect,” “plan,” “believe,” “intend,” “look forward,” and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement. Risks facing the Company and its planned platform are set forth in the Company’s filings with the SEC. Except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

Investors Contact :

Dave Gentry
RedChip Companies Inc.
1-800-RED-CHIP (733-2447)
Or 407-491-4498
Dave@redchip.com

Monday, March 1st, 2021 News No Comments

$AMST to Focus on Whole Enterprise Solutions After Successful Platform Implementation

Amesite (NASDAQ: AMST), an ed-tech, software-as-a-service (“SaaS”) company with the industry’s most advanced artificial intelligence-driven online learning platform, today announced the successful implementation of its whole enterprise solution for the Henry Ford Museum of American Innovation. “Being able to bring an entire organization into the Amesite platform is a crucial benchmark for the future of artificial intelligence-backed training and upskilling programs. We developed these solutions and scaled their capacity because we are increasingly hearing from companies that there is a critical need for wholesale improvement in the way they create and deliver content,” said Amesite CEO and Founder Dr. Ann Marie Sastry. “Businesses and educational institutions are looking for cloud-based solutions that are engaging, easy-to-use, and deliver concrete measurable results, especially now that many companies are dealing with split remote and in-person workforces.”

To view the full press release, visit https://ibn.fm/kpzP3

About Amesite Inc.

Amesite is an ed-tech, software-as-a-service (“SaaS”) company with the most advanced artificial intelligence-driven online learning platform in the industry, providing both content creation and a best-in-class infrastructure for the multibillion online learning markets in business and education. For more information, visit www.Amesite.com.

NOTE TO INVESTORS: The latest news and updates relating to AMST are available in the company’s newsroom at http://ibn.fm/AMST

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Monday, March 1st, 2021 News No Comments

$XPHYF Releases Update on Promotional and Marketing Activity Comments

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator focused on next-generation drug delivery, diagnostic and new active pharmaceutical ingredient investment opportunities, has provided an update to its Jan. 22, 2021, press release regarding recent promotional and investor relations. The updated comments were made at the request of IIROC and the Canadian Securities Exchange (“CSE”). The comments are specifically in regard to a newsletter published by WallStreetAlerts, on behalf of the company. In addition to the updated comments, the company reminded investors that the best source for full disclosure about the company is the company itself, as well as SEDAR or CSE profile pages for regulatory filings and news releases. The company acknowledges that prior to the date of this news release, XPhyto had not comply with CSE requirements to complete and post Form 10 Notices of Proposed Significant Transactions disclosing its contracts with the third-party providers. The company has now completed and posted all required forms to the CSE and will continue to do so in the future.

To view the full press release, visit: https://ibn.fm/UaAJn

About XPhyto Therapeutics Corp.

XPhyto Therapeutics is a bioscience accelerator focused on next-generation drug delivery, diagnostic and new active pharmaceutical ingredient investment opportunities including precision transdermal and oral dissolvable drug formulations; rapid, low-cost infectious disease and oral-health screening tests; and standardization of emerging active pharmaceutical ingredients for neurological applications, including psychedelic compounds and cannabinoids. XPhyto has research and development operations in North America and Europe, with an operational focus in Germany, and the company is currently focused on regulatory approval and commercialization of medical products for European markets. For more information about this company, please visit www.XPhyto.com

NOTE TO INVESTORS: The latest news and updates relating to XPHYF are available in the company’s newsroom at http://ibn.fm/XPHYF

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Monday, March 1st, 2021 News No Comments

$XPHYF Vermont Legislators Draft Drug, Psychedelic Decriminalization Bills for 2021 Session

Legislators in Vermont are planning to introduce no fewer than two measures to decriminalize drug possession this legislative session.

In an interview, State Rep. Brian Cina stated that the bill he plans to introduce would eliminate penalties imposed on a range of fungi and plant-based psychedelics, including DMT, psilocybin, ibogaine and mescaline.

In a press conference, Rep. Selene Colburn stated that a bill she was working on would decriminalize all drugs was being drafted and would be introduced later in the session. Colburn stated that legislators were still working out the model, adding that they would probably use Oregon’s measure as a guide. The state of Oregon decriminalized all drugs through a ballot measure during the November 2020 elections.

Chittenden County state attorney Sarah George stated that drugs weren’t illegal because they were dangerous but being illegal did make them more dangerous. She explained that everything was much safer when it was regulated and legalized, adding that compared to illegal drugs, legal drugs were much safer.

Another measure that’s currently being drafted for the upcoming legislative session could regulate kratom sales and decriminalize buprenorphine. The former is a painkiller alternative and herbal medicine while the latter is utilized as a treatment for opioid use disorder. Cina stated that a separate legislation, dubbed the Kratom Consumer Protection Act, would be used to help regulate sales and legalize the kratom. The legislation would establish a minimum age for purchasing the drug and outline rules that would help ensure product dosage and purity.

While there are those in favor of the decriminalization of all drugs, others oppose measures to do so, arguing that it would be a step too far. Attorney General TJ Donovan recently stated on a podcast that he supported some drug reform policies and acknowledged that drug reform policies could decrease harm. However, he noted that he could not, philosophically speaking, wrap his head around how public health or public safety could be improved by decriminalizing heroin.

Despite this though, Donovan asserted that he was open to ideas such as safe injection sites. He said that people shouldn’t shy away from tough conversations as progress was made, adding that people should be guided by both data and science as they make informed decisions.

Legislators from other states such as Virginia, KansasFlorida and Connecticut are also considering drug policy and psychedelics reform bills for the 2021 session.

Meanwhile, Canada-headquartered XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) has vowed to press ahead with its 2021 plans of developing psychedelic drug formulations, especially those that will be administered through sublingual or transdermal methods.

NOTE TO INVESTORS: The latest news and updates relating to XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) are available in the company’s newsroom at https://ibn.fm/XPHYF

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.PsychedelicNewsWire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
www.PsychedelicNewsWire.com
415.949.5050 Office
Editor@PsychedelicWire.com

PsychedelicNewsWire is part of the InvestorBrandNetwork.

Monday, March 1st, 2021 News No Comments

$WTER 420 with CNW – What Five Major Studies Say About Cannabis and Your Sex Life

Marijuana has been used for many centuries as an aphrodisiac, with early recordings showing its use in India in the seventh century. Presently, many consumers of marijuana claim that the substance improves one’s sex life. At the same time, others claim that marijuana can also affect sex negatively in different ways. However, science has shown that cannabis can improve an individual’s sex life in various ways. We look at them below.

  • Marijuana users engage in more sex

Research conducted in 2017 examined survey data collected from roughly 50,000 women and men to see if using marijuana had any influence on how often individuals had sex. They found that people who used marijuana had intercourse more frequently that people who did not. This statement remained unchanged for both women and men in every demographic group. Additionally, the study discovered that the use of marijuana did not diminish sexual function.

  • Women who use marijuana have more satisfying orgasms

Research carried out in 2019 found a connection between orgasms in women and marijuana. Researchers in the study surveyed 373 female patients at a gynecological and obstetrics practice and discovered that 127 of them consumed marijuana before engaging in intercourse, which increased their chances of having a satisfactory orgasm compared to women who did not use marijuana. Furthermore, those who consumed marijuana more frequently had higher chances of achieving a satisfying orgasm than those who consumed marijuana on occasion.

  • Marijuana connected to better women’s sexual health

study conducted last year assessed a group of women who consumed marijuana as well as the survey that examined the link between their sexual health and marijuana use. The survey was made up of questions on pain, desire, satisfaction, orgasms, lubrication and arousal; these are factors most commonly used to  assess sexual health in females.

The researchers found that women who consumed marijuana often usually scored higher on various sexual health measures, in particular satisfaction, sexual desire, orgasms and arousal. This was in comparison to women who consumed marijuana less frequently.

This remained unchanged regardless of how the weed was consumed or the type of marijuana consumed.

  • Marijuana may better men’s erectile function

A 2011 study that reviewed literature on the link between male sexual function and marijuana found inconclusive results with some studies demonstrating negative effects on male sexual health and others finding positive effects, with study authors going as far as concluding that marijuana could possibly boost erectile function. However, more research is needed on this topic.

  • Women who use marijuana experience less pain and have a higher sexual urges.

study carried out in 2017 surveyed 289 women and found that the majority of them admitted to the medicinal plant boosting their interest in sex. An estimated 77% also reported that marijuana use decreased their pain during sex.

Meanwhile, The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) has relied on innovation as well as expansion to grow from making alkaline water to adding a product line of CBD-infused capsules, drinks, tinctures and gummies.

NOTE TO INVESTORS: The latest news and updates relating to The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) are available in the company’s newsroom at http://cnw.fm/WTER

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Monday, March 1st, 2021 News No Comments

$TOBAF Announces Online Site Racks Up CDN$100,000 Sales After Only Five Days, Adds New Taste Explorer Option

March 1, 2021

TAAT Lifestyle & Wellness Ltd. (CSE: TAAT) (OTCQB: TOBAF) Announces Online Site Racks Up CDN$100,000 Sales After Only Five Days, Adds New Taste Explorer Option

  • Online sales of new TAAT tobacco-free, nicotine-free option totals CDN$100,000 sales in only five days
  • TryTAAT site launched on Feb. 17 with cartons of TAAT Original, Smooth and Menthol available for purchase
  • “February has been a very productive month for us here at TAAT,” says CEO, citing list of achievements

Within the first five days of the launch of its e-commerce portal, TAAT Lifestyle & Wellness (CSE: TAAT) (OTCQB: TOBAF) reported that its flagship product — TAAT(TM), a tobacco-free and nicotine-free alternative to traditional cigarettes offered in Original, Smooth and Menthol —had totaled more than CDN$100,000 in sales, with $48,000 of that coming in the first 48 hours (https://ibn.fm/cyc6O). Those numbers confirm what the TAAT team has known since the launch of the product only two months ago: legal-age smokers are eagerly looking for a nicotine- and tobacco-free smoking experience (https://ibn.fm/0mrwU).

A life sciences company committed to providing that kind of smoking experience to adult smokers, TAAT lunched its e-commerce portal last Wednesday at 9 a.m. ET (https://ibn.fm/snLKs). Designed to allow smokers aged 21 years and older to purchase TAAT’s flagship product, the TryTAAT site has delivered beyond what TAAT management expected.

“To sell more than CDN$100,000 worth of a relatively new product in such a short period is absolutely exceptional,” said TAAT CEO Setti Coscarella. “Countless smokers aged 21-plus in the United States have been eagerly awaiting the launch of our online store on Wednesday, which I believe has contributed significantly to our product sales this past week.”

The site launched on Wednesday, with cartons of TAAT Original, Smooth and Menthol available for purchase by adult-age smokers and shipment to addresses in eligible jurisdictions. Shortly after the initial launch, a Taste Explorer Bundle was added to the site, consisting of one 20-stick pack of each of the three TAAT varities. In addition, the company’s TryTAATpromotion remains active, in which adult smokers in eligible states can request a complimentary sample pack of the TAAT variety of their choice.

TAAT is pioneering a new concept with TAAT, its tobacco-free and nicotine-free smoking alternative. TAAT’s base material is Beyond Tobacco, a proprietary blend that undergoes a patent-pending refinement technique causing its scent and taste to resemble tobacco. TAAT products were first unveiled in various retail locations throughout Ohio, where an estimated 60% of retailers who carried the product for at least three weeks have reordered at least once (https://ibn.fm/9W75P).

“Our iterative rollout of TAAT in the United States has been very strategically planned to test the initial reactions of smokers aged 21-plus when introduced to the concept of a nicotine-free and tobacco-free smoking experience, while also gauging reception of the product after it is sampled for the first time,” said Coscarella. “Over the past two months, we have had the opportunity to gather quite a bit of feedback about TAAT from smokers aged 21-plus as well as retailers and wholesalers of tobacco. I believe those insights have proven useful, as they played a role in creating our strategies for launching the TAAT online store on Wednesday, which has been a remarkable success so far. . . .

“February has been a very productive month for us here at TAAT,” he continued. “In addition to launching our e-commerce portal and selling over CDN$50,000 worth of TAAT in 48 hours, we also secured our engagement with a major CPG sales agency, landed our first mainstream nationwide media coverage in ‘Forbes,’ and boosted our manufacturing rate by 233%. All of our initiatives for bringing TAAT to market in the United States are strategically coordinated, and I believe that e-commerce plays a significant role in providing us the opportunity to sell TAAT to smokers aged 21+ all across the United States while complementing our Ohio retail activities and a nationwide rollout with the CPG sales agency set to begin next week.”

Under executive leadership with Big Tobacco pedigree, TAAT was launched in the United States in Q4 2020 and is focused on positioning itself in the $814 billion global tobacco industry.

For more information, visit the company’s website at www.TAATGlobal.com.

NOTE TO INVESTORS: The latest news and updates relating to TOBAF are available in the company’s newsroom at https://ibn.fm/TOBAF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork.

Monday, March 1st, 2021 News No Comments

$TOBAF Enters into MOU with BC Life Sciences Firm

TAAT(TM) Lifestyle & Wellness (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2), a life sciences company dedicated to giving legal-aged smokers the choice to keep the smoking experience that they enjoy with no nicotine and no tobacco, announced plans to expand into Canada with its recently signed memorandum of understanding (“MOU”). The agreement with Christina Lake Cannabis Corp. (CSE: CLC) outlines a partnership between the two companies to develop and distribute TAAT(TM) for the Canadian market. According to the MOU, CLC will have exclusive rights to develop and distribute TAAT in Canada for a two-year renewable time period. In the announcement, TAAT noted that considerable interest for its products exists in Canada, which has a population of more than 37 million, even though the company has not done any product marketing there. Through its existing licenses, CLC can procure hemp biomass from third-party growers, produce TAAT’s Beyond Tobacco base material, and then manufacture and distribute TAAT through authorized wholesale and retail channels across Canada. “We are very pleased to have partnered with CLC, giving us the opportunity to bring TAAT to legal-aged smokers in Canada, many of whom have shown great enthusiasm about the product,” said TAAT CEO Setti Coscarella in the press release. “During my time in the tobacco industry, it was widely known that Canada was an exceptionally complex region in which to do business because of challenging regulations. Likewise, for products such as TAAT, which utilize hemp, the licensing requirements frequently represent a barrier to entry, often requiring products to be made or distributed through a Licensed Producer such as CLC. We have contemplated several international markets to which TAAT could expand first, and I believe that Canada is the ideal play based on the existing interest we already have from legal-aged smokers across Canada, a positive relationship with CLC to develop and distribute the product on our behalf, and a marketplace where the affordable price point of TAAT adds to its value proposition as a better choice.”

To view the full press release, visit http://ibn.fm/dmNq7

About TAAT Lifestyle & Wellness Ltd.

TAAT Lifestyle and Wellness has developed TAAT,  which is a tobacco-free and nicotine-free alternative to traditional cigarettes offered in Original, Smooth and Menthol varieties. TAAT’s base material is Beyond Tobacco(TM), a proprietary blend that undergoes a patent-pending refinement technique causing its scent and taste to resemble tobacco. Under executive leadership with Big Tobacco pedigree, TAAT was launched first in the United States in Q4 2020 as the company seeks to position itself in the $814 billion global tobacco industry. For more information, please visit www.TAATGlobal.com.

NOTE TO INVESTORS: The latest news and updates relating to TOBAF are available in the company’s newsroom at http://ibn.fm/TOBAF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Monday, March 1st, 2021 News No Comments

$SRAX Subsidiary LD Micro Regenerates Company Index to Reveal 423 New Players in MicroCap Space

March 1, 2021

SRAX Inc.’s (NASDAQ: SRAX) Subsidiary LD Micro Regenerates Company Index to Reveal 423 New Players in MicroCap Space

  • LD Micro reconstitutes index to reveal 35.73% increase over 2020, 423 new listings for total of 1,189 companies
  • Index includes US and Canadian companies with market cap between $50-300 million, average daily traded value of $50,000 in previous quarter
  • LD Micro is subsidiary of SRAX, provider of Sequire SaaS investor analytics platform

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through its Sequire SaaS platform, recently announced that its LD Micro subsidiary reconstituted its North American microcap index to reveal a 35.72% increase of 423 new listings for a total of 1,189 companies (https://ibn.fm/a7p3d).

LD screens companies based on selection criteria that include market cap, trading value, listing, and filing information. To qualify for inclusion on its list, companies must be listed in the United States or Canada, have a market cap between $50 million and $300 million, an average daily traded value of $50,000 in the last quarter, and a 10Q or 10K filed in the preceding calendar year (https://ibn.fm/4fQXR).

“I cannot believe what I’ve seen in the past year,” said Chris Lahiji, President of LD Micro (https://ibn.fm/jOYwN). “The LD Micro Index has more than tripled from its March 2020 lows. The tiniest public companies were also some of the biggest winners last year, and already year-to-date. As each day goes by, the Index becomes more and more consequential to the next generation of great companies.”

Lahiji founded LD Micro as an independent resource to the microcap world in 2006, growing it quickly to become the premier event platform in the space. Following the identification of potential synergies with Sequire – SRAX’s SaaS platform that unlocks investor intelligence for private companies – LD micro was acquired by SRAX in September of 2020.

“LD Micro is, without a doubt, one of the most well-known and respected brands in micro-cap,” said SRAX CEO and founder Christopher Miglino. “Chris Lahiji and his team have done an incredible job of creating a loyal community of investors and issuers.”

Sequire empowers public companies with critical insights into the activities of both retail and institutional investors, helping them create and activate successful campaigns aimed at increasing investor engagement. Since 2019, the SaaS platform has grown to over 3 million active users that include investors and traders from over 90 public companies (https://ibn.fm/L8hSO).

In addition to Sequire, SRAX focuses on building the largest and most reliable opted-in data sets that span a broad range of industry verticals. As the power of data continues to increase across the digital landscape, the Company continues to focus on its mission to provide brands and companies across the CPG, luxury, lifestyle and financial spaces with high-quality data that provides key, actionable insights integral to strategic marketing campaigns.

For more information, visit the company’s website at www.SRAX.com

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

 

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork.

Monday, March 1st, 2021 News No Comments

$PLTXF Announces Results of Annual and Special Meeting

PlantX Life (CSE: VEGA ) (Frankfurt: WNT1) (OTCQB: PLTXF), a multifaceted marketplace providing consumers all things plant based, has released results of its recent annual and special shareholder meeting. The meeting was held Feb. 26, 2021, and during the meeting, shareholders nominated and elected five board members: Quinn Field-Dyte, Lorne Rapkin, Peter Simeon, Alex Hoffman and Ralph Moxness. The company noted that incumbent director Todd Shapiro did not seek re-election at the meeting. Alex Hoffman and Ralph Moxness were elected to the board of directors for the first time. During the course of the meeting, shareholders passed all other motions on the agenda, including fixing the number of directors of the company to five and appointing Dale Matheson Carr-Hilton Labonte LLP, Chartered Professional Accountants. The shareholders also approved, ratified and confirmed the company’s proposed stock option plan, restricted share unit plan, and performance share unit plan, as well as approving, ratifying and confirming the grants of 4,703,000 restricted share units and 3,950,000 performance share units. “On behalf of the board and management team, we would like to thank Todd Shapiro for his service and valuable contributions as a director and wish him the best as he continues to focus on his full-time job as chief executive officer of Red Light Holland,” said PlantX chief financial officer Lorne Rapkin in the press release. “We look forward to continuing to work with Todd as a consultant to the Company advising in marketing, media and social media strategies.”

To view the full press release, visit: https://ibn.fm/S9UF2

About PlantX Life Inc.

As the digital face of the plant-based community, PlantX’s platform is the one-stop-shop for everything plant-based. With its fast growing category verticals, the Company offers customers across North America more than 10,000 plant-based products. In addition to offering meal and indoor plant deliveries, the Company currently has plans underway to expand its product lines to include cosmetics, clothing, and its own water brand — but the business is not limited to an e-commerce platform. The Company uses its digital platform to build a community of like-minded consumers, and most importantly, provide education. Its successful enterprise is being built and fortified on partnerships with top nutritionists, chefs and brands. The Company eliminates the barriers to entry for anyone interested in living a plant-based lifestyle, and thriving in a longer, healthier and happier life. For more information about this company, please visit www.PlantX.com and www.PlantX.ca.

NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at http://ibn.fm/PLTXF

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Monday, March 1st, 2021 News No Comments

$KAVL Adds Two New Distribution Partners, Additional Opportunity for Revenue Growth

Kaival Brands (OTCQB: KAVL), a company focused on generating stockholder value by incubating innovative products into mature and dominant brands, is the exclusive global distributor of all products manufactured by Bidi Vapor LLC. Bidi Vapor’s primary offering, the Bidi(R) Stick, is the fastest-growing closed system vaping product in the U.S. and the only vape product on the market with an ecologically friendly, mass-recycling program. Kaival Brands today announced two new distribution partners for Bidi Vapor’s product line: Imperial Trading with a network in the South, Southeast and Midwest and Chambers & Owen with a network throughout the Midwest. According to the update, the two new agreements boost the potential store count for Bidi Vapor products to over 54,000, up from 10,000 for all of 2020. “These two new additional partners represent another revenue growth opportunity for Bidi and Kaival,” said Niraj Patel, CEO of Kaival Brands. “Between last week’s announcement regarding PMTA’s filing letter acceptance, our exclusive partnership with goPuff, new distribution agreements with Hilmes, Avail and Smoker Friendly, we are feeling extremely confident about our fiscal year 2021 revenue guidance range of $400m – $450 million.”

To view the full press release, visit http://ibn.fm/6jSIp

About Kaival Brands Innovations Group Inc.

Kaival Brands is a company focused on growing and incubating innovative and profitable products into mature and dominant brands in their respective markets. The company’s vision is to develop internally, acquire, own, or exclusively distribute these innovative products and grow each into dominant market-share brands with superior quality and recognizable innovation. For more information, visit the company’s website at www.KaivalBrands.com.

NOTE TO INVESTORS: The latest news and updates relating to KAVL are available in the company’s newsroom at http://ibn.fm/KAVL

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Monday, March 1st, 2021 News No Comments

$IDEX Listed Among 4 Hot EV Stocks To Watch In March 2021 by PennyStocks.com

A Bullish Trend For Electric Vehicle Penny Stocks Continues Growing In March

Last week’s market pullback hit the reset button for countless penny stocks . Many of these names were the center of FOMO (fear of missing out) across several social media channels, including Reddit, Facebook, and Twitter. One of the groups of penny stocks that traders were FOMOing about was electric vehicle stocks.

Last year and into 2021, the overly bullish sentiment for things like EV and green energy triggered a massive uptrend in related stocks. Believe it or not, many of the notable names among electric vehicle stocks were once trading as penny stocks ; yes, this includes the beloved Nio NYSE: NIO ). In turn, traders scrambled to find “the next NIO,” “the next PLUG,” or the next “whatever” similar name to buy.

After last week’s dip, many of the overinflated names consolidated back to major technical levels. The ones I’m referring to are 50-day and 200-day moving averages. Now, at the start of March, the markets are monitoring the situation closely. Will these major moving averages hold as new support, or is a further sell-off to ensue? While time will certainly tell, what I can say for sure is that the fervor for electric vehicle penny stocks hasn’t subsided one bit at the beginning of March. Many companies with at least a little exposure to the industry are grabbing attention.

Electric Vehicle Penny Stocks Take Center Stage In March

Since this industry is still very new, it’s understandable that the markets are attracted to companies undertaking this early stage expansion. With the likes of Tesla and, now Lucid Motors emphasizing a need for more electric vehicle options, momentum is beginning to build once again. Will this sentiment remain a factor in March? We’ll have to see but in the meantime, here are a few hot penny stocks to watch that’ve gained in light of recent EV industry momentum.

Electric Vehicle Penny Stocks To Watch

  1. Aqua Metals Inc. NASDAQ: AQMS )
  2. Medigus Ltd. NASDAQ: MDGS )
  3. Ault Global Holdings Inc. NYSE: DPW )
  4. Ideanomics Inc. NASDAQ: IDEX )

Aqua Metals Inc.

This company was one of the hottest penny stocks to watch for the better part of the last few months. We wrote about it until it finally ended up leaving penny stock territory. AQMS traded at highs of $8.06 last month. Thanks to the market’s broad pull-back, Aqua Metals has flirted with the $5 limit of this penny stock range. Needless to say, aside from selling-off with the rest of the market, not much else has suggested a bearish sentiment surrounding AQMS stock.

[Read More] 3 Penny Stocks To Buy According To Analysts With Targets Up To 168%

At the heart of it, Aqua Metals is a metals recycling company. Its processes also include battery recycling. So you could qualify this as more of a “pick and shovel” in the world of electric vehicle penny stocks. Its recycling process allows for the extraction of valuable materials that can then be redistributed back into the industry as raw materials—things like plastics, lead, and other metallics. Aqua has also secured investment in LINICO Corporation, a cleantech lithium-ion battery recycling company, which adds a bit more excitement into the mix. There’s also been a provisional patent submitted to protect its process for applying its AquaRefining technology to plate metals used in lithium-ion batteries.

Aqua Metals recently reported its 2020 results beating its prior year’s EPS but coming up short compared to sales. However, management is optimistic about the year ahead.

“Our recent decision to enter into a lease-to-buy agreement with LiNiCo, a company focused on lithium-ion battery recycling, resulted in a shift from a planned plant sale to a strategic lease. As we announced on February 16, the arrangement created many advantages for Aqua Metals,” explained Steve Cotton, President, and Chief Executive Officer.

electric vehicle penny stocks to buy Aqua Metals Inc. AQMS stock chart

Medigus Ltd.

While it isn’t a pick and shovel company like Aqua Metals, Medigus is a bit more diversified, not having 100% exposure to electric vehicles only. The company has a wide variety of projects in its pipeline. However, for this article, we’ll focus on its EV operations.

Last month, Medigus formed a joint venture with EMuze Founders to create what it’s calling a micro-mobility EV. In particular, this EV is being designed for ‘last-mile’ applications. This news followed another EV-related headline where the Medigus subsidiary, Charging Robotics Ltd, began developing a robotic wireless charging pad for electric vehicles.

Does this mean you’ll be able to charge your car like your smartphone? According to Medigus, “an on-demand autonomous charging system is intended to be used anywhere and anytime. The wireless charging system being developed is intended to be self-aligning to electric vehicle battery chargers. The state-of-the-art autonomous Wireless Power Transfer technology, once developed, is intended to seamlessly and efficiently charge the vehicle upon demand, and it will carry the Wireless Power Transfer from charging station or charging truck to a customer’s vehicle that needs electric charging.”

While the story develops, Medigus continues to bring in new capital for operations. This week, the company officially closed its latest $8.5 million round.

electric vehicle penny stocks to buy Medigus Ltd. MDGS stock chart

Ault Global Holdings Inc.

Another company with operations not solely focused on EVs is Ault Global. The company offers a wide range of products through its subsequent companies—everything from green energy to cryptocurrency-related products & services. Again, for this article, we will focus on the EV applications from Ault. Namely, the company’s Coolisys business has just launched electric vehicle charging units. The ACEVool 7kW residential electric vehicle systems have now hit the market, and Ault announced it has already received an order for 5,000 units.

“We believe our EV charger product line will be well-positioned to address the expected rapid expansion of infrastructure required to support broad adoption of electric vehicles globally,” explained Coolisys’ President and CEO, Amos Kohn.

I will take an aside right now and say that the EV niche is one small piece of Ault Global. The company has taken up a very different model in 2021, thanks to its fundraising efforts. Ault raised over $160 million within the last 4 months so far. It has then taken this cash and deployed it using an activist investor strategy.

[Read More] How To Buy Penny Stocks in 2021

Take a look at some of the filings from other public companies like NTN Buzztime NYSE: NTN ) or SilverSun Technologies, Inc. NASDAQ: SSNT ), and you’ll see what I mean. Ault Global has taken 9%+ stakes in these companies. While this isn’t really a new strategy as Ault has invested in many private businesses, this new approach now sees the company investing in publicly-traded ones.

electric vehicle penny stocks to buy Ault Global Holdings Inc. DPW stock chart

Ideanomics Inc.

IDEX stock has been on our watch list for months at this point. In fact, over the last 12 months, the penny stock has climbed from under 40 cents to as high as $5.53 this year. Obviously, Ideanomics suffered the same sell-off that broader markets faced late last month. Like most, it pulled back to its 50-day moving average and has been consistently holding this level as support.

As far as electric vehicles and Ideanomics are concerned, a few things are going on right now. Most recently, the company’s portfolio company, Solectrac, has been ramping up for expanding its vehicle reservation campaign. Solectrac develops all-electric tractors. According to the company, it’s the first North American manufacturer & distributor of zero-emission electric tractors. The retail prices range from $29,800 to $55,000, so we’re not talking about personal “John Deere” tractors for your front yard.

Ideanomics’ Mobile Energy Global division is also focused on electric vehicles. In this capacity, the company has focused on selling ride-hailing vehicles for the Chinese market. In tandem with this, Ideanomics is also signed a definitive agreement to acquire Wireless Advanced Vehicle Electrification, Inc. This gets the company into the electric vehicle charging niche, further expanding its integration strategy in the electric vehicle industry.

electric vehicle penny stocks to buy Ideanomics Inc IDEX stock chart

News Provided by PennyStocks.com via QuoteMedia

Monday, March 1st, 2021 News No Comments

$UUUU Poised for Growth as Uranium Price Expected to Increase

  • Industry leaders remain hopeful that 2021 will be positive year for uranium market
  • Demand outstrips supply as global push for carbon-free energy source gains momentum amid muted supply
  • As the leading U.S. uranium producer, Energy Fuels is ready to leverage growing market opportunity, remain at forefront of U.S. nuclear energy space

After years of stagnation, industry leaders are confident that the uranium market is going through a revival, heading for potentially rapid growth in the coming years. As a leading U.S. uranium producer, Energy Fuels (NYSE American: UUUU) (TSX: EFR) appears poised to seize on the growing calls for nuclear energy to be deployed to help address climate change and reduce air pollution.

Uranium prices have been depressed for several years, as demand dropped after the 2011 Fukushima disaster in Japan. However, supply shortages and the global quest for alternative, low-carbon power sources have renewed interest in this market.

A recent article published by “Investing News” cites industry leaders feeling optimistic about the direction of the market in 2021 on the back of the strong fundamentals that can drive robust growth. Increasingly recognized as an essential part of the clean energy mix, nuclear energy could significantly increase its share of global electricity production from the current 10%. Nuclear provides 20% of U.S. electricity, and 55% of the carbon-free electricity produced in the country.

The uranium price has increased by more than 20% over the past year to around $30 as longer-term fundamentals are expected to remain strong for the sector (https://ibn.fm/MTv5D). Based on cost-curve support calculations, the long-term sustainable uranium spot price is most likely in the $40–$50 per pound range with a potential multiyear spike to $80/lb, according to a recent industry research (https://ibn.fm/ag0AA).

The article features Energy Fuels vice president of marketing and corporate development Curtis Moore, who points out that years of stagnation have potentially led to uranium’s moment as demand continues to exceed supply. Inventory reduction, deposit depletion and continued high grading indicate the potential for strong price performance in the coming years.

Moore also notes that prices are still below the level needed to accelerate production. Despite activity increasing in 2020, there are still inventories available in the market, he notes, but they are being depleted and at some point will need to be replaced. This could happen at a price that incentivizes mine production, and this price is much higher than what we see reported today, he said.

“We think there are definitely better uranium markets ahead,” said Moore. “The realizable sales price for uranium is below most miners’ cost of production, which is unsustainable. In many ways, history is repeating, and we might be in the beginning of the next run in uranium prices. We don’t know when the market will recover, but it will.”

As a leading uranium producer, Energy Fuels appears well positioned to seize the market opportunity as the industry heads for a potential price surge.

For more information, visit the company’s website at www.EnergyFuels.com.

NOTE TO INVESTORS: The latest news and updates relating to UUUU are available in the company’s newsroom at http://ibn.fm/UUUU

About MiningNewsWire 

MiningNewsWire (MNW) is a specialized communications platform focused on developments and opportunities in the global resources sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, MNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MNW brings its clients unparalleled visibility, recognition and brand awareness. MNW is where news, content and information converge.

To receive SMS text alerts from MiningNewsWire, text “BigHole” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Los Angeles, California
www.MiningNewsWire.com
310.299.1717 Office
Editor@MiningNewsWire.com

MiningNewsWire is part of the InvestorBrandNetwork.

Monday, March 1st, 2021 News No Comments

$POAI Looks to AI to Improve Clinical Decision Making for Ovarian Cancer Patients

Predictive Oncology (NASDAQ: POAI), through its wholly owned subsidiary, Helomics, has sought to end the alarming statistics surrounding ovarian cancer. According to figures provided by the American Cancer Society and quoted by an article discussing POAI’s motivations and operations, “an estimated 21,750 women received a new diagnosis of ovarian cancer this year (2020), and almost 14,000 women will die from the disease. Those numbers make ovarian cancer the fifth-leading cause of cancer deaths in women.” In a bid to change this reality, Predictive Oncology, a company that focuses on using data and artificial intelligence to develop personalized cancer therapies, has partnered with the University of Pittsburg School of Medicine, through Helomics, “to study the use of artificial intelligence (‘AI’) to improve clinical decision making for ovarian cancer patients. The collaboration entails using Helomics’ AI platform and proprietary data to analyze the genomic and drug response profiles of women with ovarian cancer to evaluate predictive values in terms of response and non-response to different treatments… Helomics’ predictive models will save time and money in the search for new targeted therapies.”

To view the full article, visit: https://ibn.fm/qsDz5

About Predictive Oncology Inc.

Predictive Oncology operates through three segments (Skyline, Helomics and Soluble Biotech), which contain four subsidiaries: Helomics, TumorGenesis, Skyline Medical and Soluble Biotech. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. TumorGenesis Inc. specializes in media that help cancer cells grow and retain their DNA/RNA and proteomic signatures, providing researchers with a tool to expand and study cancer cell types found in tumors of the blood and organ systems of all mammals, including humans. Skyline Medical markets its patented and FDA cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. Soluble Biotech is a provider of soluble and stable formulations for proteins, including vaccines, antibodies, large and small proteins and protein complexes. For more information, visit the company’s website at www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Friday, February 26th, 2021 News Comments Off on $POAI Looks to AI to Improve Clinical Decision Making for Ovarian Cancer Patients